Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online ahead of print on 3 September 2009 as doi:10.1099/mic.0.027995-0
Microbiology (2009), DOI 10.1099/mic.0.027995-0
© 2009 Society for General Microbiology

This Article
Right arrow Full Text (Papers in Press[PDF])
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Brehony, C.
Right arrow Articles by Maiden, M. C.J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brehony, C.
Right arrow Articles by Maiden, M. C.J.
Agricola
Right arrow Articles by Brehony, C.
Right arrow Articles by Maiden, M. C.J.
Microbiology 0 (2009), mic.0.027995; DOI  10.1099/mic.0.027995-0
© 2009 Society for General Microbiology


Variation of the factor H-binding protein of Neisseria meningitidis

Carina Brehony1,4, Daniel J Wilson2 and Martin C.J. Maiden3

1 University of Oxford;
2 University of Chicago;
3 Univeristy of Oxford

There is currently no comprehensive meningococcal vaccine, due to difficulties in immunising against organisms expressing serogroup B capsules. To address this problem, sub-capsular antigens, particularly the outer membrane proteins (OMPs), are being investigated as candidate vaccine components. If immunogenic, however, such antigens are often antigenically variable and knowledge of the extent and structuring of this diversity is an essential part of vaccine formulation. Factor H-binding protein (fHbp) is one such protein and is included in two vaccines under development. A survey of the diversity of the fHbp gene and the encoded protein in a representative sample of meningococcal isolates confirmed that variability in this protein is structured into two or three major groups, each with a substantial number of alleles that have some association with meningococcal clonal complexes and serogroups. A unified nomenclature scheme was devised to catalogue this diversity. Analysis of recombination and selection on the allele sequences demonstrated that the parts of the gene are subject to positive selection, consistent with immune selection on the protein generating antigenic variation, particularly in the C-terminal region of the peptide sequence. The highest levels of selection were observed in regions corresponding to epitopes recognised by previously described bactericidal monoclonal antibodies.

4 E-mail: carina.brehony{at}zoo.ox.ac.uk







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2009 Society for General Microbiology.